Standard Guide for Accelerated Aging of Sterile Barrier Systems and Medical Devices

SIGNIFICANCE AND USE
4.1 The loss of sterile barrier system integrity may occur as a result of physical properties of the materials and adhesive or cohesive bonds degrading over time or by subsequent dynamic events during shipping and handling, or both. Accelerated and real time aging verifies the time-related aspects of potential integrity loss only.  
4.2 ANSI/AAMI/ISO 11607–1: 2019, sub-clause 6.1.3, states that “the packaging system shall provide physical protection in order to maintain integrity of the sterile barrier system.” Sub-clause 6.1.6 states that, “A terminally sterilized sterile barrier system with its protective packaging, if included, shall be designed to, maintain sterility through exposure to expected conditions and hazards during the specified processing, storage, handling, and distribution until that SBS is opened at the point of use or until the expiry date.” Sub-clause 8.3.1 states, “Stability testing shall demonstrate that the sterile barrier system maintains integrity over time.” Sub-clause 8.3.3 states, “Stability testing, using accelerated aging protocols, shall be regarded as sufficient evidence for claimed expiry dates until data from real-time aging studies are available.”  
4.3 Real time aging programs provide the best data to ensure that sterile barrier system/medical device materials and sterile barrier system/medical device integrity do not degrade over time. However, due to market conditions in which products may become obsolete in a short time, and the desire to get new products to market in the shortest possible time, real time aging studies do not meet this objective. Accelerated aging studies can provide an alternative means of screening for possible aging-related failure mechanisms in the SBS or medical device. To ensure that accelerated aging studies represent real time effects, real time aging studies must be conducted in parallel to accelerated studies. Real time studies must be carried out to the claimed shelf life of the product and be perf...
SCOPE
1.1 This guide provides information for developing accelerated aging protocols to model the possible effects of the passage of time on the sterile integrity of the sterile barrier system (SBS), as defined in ANSI/AAMI/ISO 11607–1: 2019 and the physical properties of their component packaging materials. Guidance for developing accelerated aging protocols may also be used for medical devices and medical device materials.  
1.2 Information obtained using this guide may be regarded as sufficient evidence for expiration date claims for medical devices and sterile barrier systems until data from real-time aging studies are available.  
1.3 The accelerated aging guideline addresses sterile barrier systems as a whole with or without devices. The sterile barrier system material and device interaction compatibility that may be required for new product development or the resulting evaluation is not addressed in this guide.  
1.4 Real-time aging protocols are not addressed in this guide; however, it is essential that real-time aging studies be performed to confirm the accelerated aging test results using the same methods of evaluation. Real-time aging (stability) is the requirement of ANSI/AAMI/ISO 11607–1: 2019.  
1.5 Methods used for sterile barrier system performance validation, which include, environmental challenge, distribution, handling, and shipping events, are used for package performance (event-related loss of integrity) testing and are beyond the scope of this guide.  
1.6 This guide does not address environmental challenging that simulates extreme climactic conditions that may exist in the shipping and handling environment. Refer to Practice D4332 for standard conditions that may be used to challenge the sterile barrier system to realistic extremes in temperature and humidity conditions. See Terminology F17 for a definition of “environmental challenging.”  
1.7 The data obtained from accelerated aging studies is no...

General Information

Status
Published
Publication Date
14-Dec-2021
Current Stage
Ref Project

Relations

Buy Standard

Guide
ASTM F1980-21 - Standard Guide for Accelerated Aging of Sterile Barrier Systems and Medical Devices
English language
8 pages
sale 15% off
Preview
sale 15% off
Preview
Guide
REDLINE ASTM F1980-21 - Standard Guide for Accelerated Aging of Sterile Barrier Systems and Medical Devices
English language
8 pages
sale 15% off
Preview
sale 15% off
Preview

Standards Content (Sample)

This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the
Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
Designation: F1980 − 21
Standard Guide for
Accelerated Aging of Sterile Barrier Systems and Medical
1
Devices
This standard is issued under the fixed designation F1980; the number immediately following the designation indicates the year of
original adoption or, in the case of revision, the year of last revision.Anumber in parentheses indicates the year of last reapproval.A
superscript epsilon (´) indicates an editorial change since the last revision or reapproval.
1. Scope the shipping and handling environment. Refer to Practice
D4332 for standard conditions that may be used to challenge
1.1 This guide provides information for developing accel-
the sterile barrier system to realistic extremes in temperature
erated aging protocols to model the possible effects of the
and humidity conditions. SeeTerminology F17 for a definition
passage of time on the sterile integrity of the sterile barrier
of “environmental challenging.”
system (SBS), as defined in ANSI/AAMI/ISO 11607–1: 2019
and the physical properties of their component packaging 1.7 The data obtained from accelerated aging studies is not
materials.Guidancefordevelopingacceleratedagingprotocols to be used as a manner of establishing label storage conditions
may also be used for medical devices and medical device for sterile barrier systems.
materials.
1.8 The values stated in SI units are to be regarded as
1.2 Information obtained using this guide may be regarded standard. No other units of measurement are included in this
as sufficient evidence for expiration date claims for medical standard.
devices and sterile barrier systems until data from real-time
1.9 This standard does not purport to address all of the
aging studies are available.
safety concerns, if any, associated with its use. It is the
responsibility of the user of this standard to establish appro-
1.3 Theacceleratedagingguidelineaddressessterilebarrier
priate safety, health, and environmental practices and deter-
systems as a whole with or without devices.The sterile barrier
mine the applicability of regulatory limitations prior to use.
system material and device interaction compatibility that may
1.10 This international standard was developed in accor-
be required for new product development or the resulting
dance with internationally recognized principles on standard-
evaluation is not addressed in this guide.
ization established in the Decision on Principles for the
1.4 Real-time aging protocols are not addressed in this
Development of International Standards, Guides and Recom-
guide; however, it is essential that real-time aging studies be
mendations issued by the World Trade Organization Technical
performed to confirm the accelerated aging test results using
Barriers to Trade (TBT) Committee.
the same methods of evaluation. Real-time aging (stability) is
the requirement of ANSI/AAMI/ISO 11607–1: 2019.
2. Referenced Documents
1.5 Methods used for sterile barrier system performance
2
2.1 ASTM Standards:
validation, which include, environmental challenge,
D4332Practice for Conditioning Containers, Packages, or
distribution, handling, and shipping events, are used for pack-
Packaging Components for Testing
ageperformance(event-relatedlossofintegrity)testingandare
E337Test Method for Measuring Humidity with a Psy-
beyond the scope of this guide.
chrometer (the Measurement of Wet- and Dry-Bulb Tem-
1.6 This guide does not address environmental challenging
peratures)
that simulates extreme climactic conditions that may exist in
F17Terminology Relating to Primary Barrier Packaging
F2097Guide for Design and Evaluation of Primary Flexible
1
This guide is under the jurisdiction of ASTM Committee F02 on Primary
Barrier Packaging and is the direct responsibility of Subcommittee F02.50 on
2
Package Design and Development. For referenced ASTM standards, visit the ASTM website, www.astm.org, or
Current edition approved Dec. 15, 2021. Published December 2021. Originally contact ASTM Customer Service at service@astm.org. For Annual Book of ASTM
approved in 1999. Last previous edition approved in 2016 as F1980–16. DOI: Standards volume information, refer to the standard’s Document Summary page on
10.1520/F1980-21. the ASTM website.
Copyright © ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959. United States
1

---------------------- Page: 1 ----------------------
F1980 − 21
Packaging for Medical Products
T = alpha temperature; heat distortion temperature.
α
2.2 Other Standards:
ANSI/AAMI/ISO 11607–1: 2019Packaging for Terminally
4. Significance and Use
3
Sterilized Medical Devices
4
4.1 The loss of sterile barrier system integrity may occur as
ASHRAE 170-20
...

This document is not an ASTM standard and is intended only to provide the user of an ASTM standard an indication of what changes have been made to the previous version. Because
it may not be technically possible to adequately depict all changes accurately, ASTM recommends that users consult prior editions as appropriate. In all cases only the current version
of the standard as published by ASTM is to be considered the official document.
Designation: F1980 − 16 F1980 − 21
Standard Guide for
Accelerated Aging of Sterile Barrier Systems forand Medical
1
Devices
This standard is issued under the fixed designation F1980; the number immediately following the designation indicates the year of
original adoption or, in the case of revision, the year of last revision. A number in parentheses indicates the year of last reapproval. A
superscript epsilon (´) indicates an editorial change since the last revision or reapproval.
1. Scope
1.1 This guide provides information for developing accelerated aging protocols to rapidly determine the effects, if any, due to
model the possible effects of the passage of time on the sterile integrity of the sterile barrier system (SBS), as defined in
ANSI/AAMI/ISO 11607–1:2006 11607–1: 2019 and the physical properties of their component packaging materials. Guidance for
developing accelerated aging protocols may also be used for medical devices and medical device materials.
1.2 Information obtained using this guide may be used to support regarded as sufficient evidence for expiration date claims for
medical device sterile barrier systems.devices and sterile barrier systems until data from real-time aging studies are available.
1.3 The accelerated aging guideline addresses the sterile barrier systems in as a whole with or without devices. The sterile barrier
system material and device interaction compatibility that may be required for new product development or the resulting evaluation
is not addressed in this guide.
1.4 Real-time aging protocols are not addressed in this guide; however, it is essential that real-time aging studies be performed
to confirm the accelerated aging test results using the same methods of evaluation. Real-time aging (stability) is the requirement
of ANSI/AAMI/ISO 11607–1: 2019.
1.5 Methods used for sterile barrier system validation, which include the machine process, the effects of the sterilization process,
environmental challenge, distribution, handling, and shipping events, are performance validation, which include, environmental
challenge, distribution, handling, and shipping events, are used for package performance (event-related loss of integrity) testing
and are beyond the scope of this guide.
1.6 This guide does not address environmental challenging that stimulatessimulates extreme climactic conditions that may exist
in the shipping and handling environment. Refer to Practice D4332 for standard conditions that may be used to challenge the sterile
barrier system to realistic extremes in temperature and humidity conditions. See Terminology F1327F17 for a definition of
“environmental challenging.”
1.7 The data obtained from accelerated aging studies is not to be used as a manner of establishing label storage conditions for
sterile barrier systems.
1.8 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.
1
This guide is under the jurisdiction of ASTM Committee F02 on Primary Barrier Packaging and is the direct responsibility of Subcommittee F02.50 on Package Design
and Development.
Current edition approved Sept. 15, 2016Dec. 15, 2021. Published September 2016December 2021. Originally approved in 1999. Last previous edition approved in
20112016 as F1980 – 07F1980 – 16.(2011). DOI: 10.1520/F1980-16.10.1520/F1980-21.
Copyright © ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959. United States
1

---------------------- Page: 1 ----------------------
F1980 − 21
1.9 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility
of the user of this standard to establish appropriate safety safety, health, and healthenvironmental practices and determine the
applicability of regulatory limitations prior to use.
1.10 This international standard was developed in accordance with internationally recognized principles on standardization
established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued
by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
2. Referenced Documents
2
2.1 ASTM Standards:
D4332 Practice for Conditioning Containers, Packages, or Packaging Components for Testing
E337 Test Method for Measuring Humidity with a Psychrometer (the Measurement of Wet- and Dry-Bulb Temperatures)
F17 Terminology Relating to Primary Barrier Packaging
3
F1327 Terminology Relating to Barrier Materials for Medical Packaging
...

Questions, Comments and Discussion

Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.